Author

J. Sjef Verbeek

Leiden University Medical CenterORCID 0000-0003-0934-6924Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Benjamin T. Zandstra· 1 shared Carly BaehriD· 1 shared Dustin HicksiD· 1 shared Geoffrey T. HartiD· 1 shared Jenna K. DickiD· 1 shared Jules A. SangalaiD· 1 shared Marco PravetoniiD· 1 shared Mark Steven CraggiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Benjamin T. Zandstra

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyThe Journal of ImmunologyPeer-reviewedAug 1, 2026

ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for in vivo efficacy against SARS-CoV-2

Jenna K. Dick, Venkatramana Divana Krishna, Dustin Hicks…·Geoffrey T. Hart

This study shows that Fc receptor engagement is necessary for the efficacy of SARS-CoV-2 therapeutics, including mAbs and BiKEs, and demonstrates the effectiveness of ACE2 decoy Fc-fusions and BiKEs against multiple variants.

DOI 10.1093/jimmun/vkag235

mouseexperimental assay

𝕏 PostBluesky